Biochemistry, Genetics and Molecular Biology
Insulin Release
100%
Gastric Inhibitory Polypeptide
60%
Glucagon-Like Peptide-1
39%
Anura
26%
Glucagon
26%
Antidiabetic Activity
26%
Glucose Homeostasis
25%
Body Weight
23%
Cell Function
20%
Glucose Blood Level
19%
Secretion (Process)
18%
Agonist
17%
Streptozotocin
17%
Ob/Ob Mouse
16%
Skin Secretion
16%
Glycation
14%
Glucagon-Like Peptide 1 Receptor
14%
N-Terminus
13%
Insulin Sensitivity
13%
Insulin Resistance
13%
Gastric Inhibitory Polypeptide Receptor
13%
Incretin
12%
Blood Plasma
12%
Amino Acids
12%
Alanine
11%
Dipeptidyl Peptidase
11%
Cyclic Adenosine Monophosphate
11%
Insulin Blood Level
11%
Biological Activity
10%
Glucose Transport
9%
Host Resistance
9%
Receptor Antagonist
9%
Arginine
8%
Enzyme
8%
Hyperglycemia
8%
Enteroglucagon
8%
Reverse Phase High Performance Liquid Chromatography
8%
Cell Survival
8%
Glucagon Receptor
8%
Animal Model
8%
Adenosine Triphosphate
8%
Gene Expression
7%
Cholecystokinin
7%
Palmitic Acid
6%
Transdifferentiation
6%
Receptor Agonists
6%
Cytotoxicity
6%
Sulfonylurea
6%
Diazoxide
6%
Metabolic Pathway
6%
Pharmacology, Toxicology and Pharmaceutical Science
Gastric Inhibitory Polypeptide
77%
Glucagon-Like Peptide-1
53%
Antidiabetic Agent
50%
Non Insulin Dependent Diabetes Mellitus
33%
Ob/Ob Mouse
25%
Diabetes Mellitus
22%
Receptor
21%
Incretin
20%
Streptozotocin
19%
Gastric Inhibitory Polypeptide Receptor
18%
Diabetic Obesity
18%
Dipeptidyl Peptidase IV
17%
Exendin 4
14%
Calcium Ion
13%
Carboxamide
12%
Biological Activity
11%
Amino Acid
10%
Alanine
10%
Tolbutamide
9%
Anura
9%
Long Term Exposure
9%
Sulfonylurea
9%
Glucagon-Like Peptide 1 Receptor
9%
Glucagon
9%
Insulin Resistance
9%
Adenosine Triphosphate
8%
Diazoxide
8%
Receptor Antagonist
8%
Liraglutide
8%
Homocysteine
8%
Oxyntomodulin
7%
Glucagon Like Peptide 1 [7-36] Amide
7%
Hyperglycemia
7%
Peptide YY
6%
Cytochrome P450
6%
Fatty Acid
6%
Cytotoxicity
5%
Nateglinide
5%
Cholecystokinin Octapeptide
5%
Metformin
5%
Arginine
5%
Receptor Agonist
5%
Insulin Dependent Diabetes Mellitus
5%
Cell Viability
5%
Isobutylmethylxanthine
5%
Desensitization
5%
Peptide Fragment
5%
Medicine and Dentistry
Gastric Inhibitory Polypeptide
58%
Beta Cell
50%
Diabetes
45%
Insulin Release
38%
Glucagon Like Peptide 1
28%
Receptor
25%
Antidiabetic Agent
21%
Maturity Onset Diabetes of the Young
18%
Pancreatic Islet
18%
Glucose Tolerance
17%
Cell Function
15%
Antidiabetic Activity
15%
Incretin
15%
Glucagon
15%
Streptozocin
15%
Diabetes Mellitus
13%
Cell Transdifferentiation
12%
Cell Line
12%
Insulin Resistance
11%
Body Weight
11%
Exenatide
10%
Ob/Ob Mouse
8%
Diabetic Obesity
8%
Glucose Homeostasis
8%
High Fat Food
8%
In Vitro
8%
Programmed Cell Death
7%
Insulin Sensitivity
7%
Secretion (Process)
7%
Alanine
7%
Cholecystokinin Octapeptide
7%
Calcium Ion
7%
Glucagon Like Peptide 1 Receptor
7%
Biological Activity
6%
Dipeptidyl Peptidase IV
6%
Liraglutide
6%
Cell Survival
6%
Bone Strength
6%
Gastrointestinal Hormone
6%
Gene Expression
5%
Caloric Intake
5%
Glucose Uptake
5%
Amino Acid
5%
Gut
5%
Hyperglycemia
5%
Diet Induced Obesity
5%
Food Intake
5%
Sitagliptin
5%
